The global Hospital Surgical Disinfectants Market is estimated to be valued at US$ 3.51 Bn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Hospital surgical disinfectants are antimicrobial-based products used for disinfecting hands, skin and medical instruments in hospitals settings. These disinfectant products helps prevent the spread of hospital-acquired infections by destroying or inhibiting the growth of microorganisms on inanimate objects. The most commonly used hospital surgical disinfectants includes skin disinfectants, instrument disinfectants, and surface disinfectants. With increasing number of surgeries and prevalence of hospital-acquired infections worldwide, the demand for effective disinfectant products is growing in hospital settings.
Market key trends:
One of the key trends in hospital surgical disinfectants market is growing adoption of non-alcohol based disinfectants. Majority of available hand disinfectants contain alcohol as active ingredient which causes skin dryness and irritation with frequent use. This has led to increasing demand for alcohol-free, gentle hand disinfectants containing ingredients like Benzalkonium chloride or triclosan. Companies are focused on launching novel non-alcohol based disinfectants specially formulated for healthcare workers with frequent hand hygiene requirements. For instance, in 2020, Ecolab launched Opticlean Plus, an advanced non-alcohol based surgical hand antiseptic for repeated hand scrubbing in healthcare facilities.
Porter’s Analysis
Threat of new entrants: The Hospital Surgical Disinfectants Market Growth requires significant capital investments for R&D, manufacturing facilities and marketing. Established brands have strong customer loyalty and regulations acts as a barrier for new players.
Bargaining power of buyers: The buyers have moderate bargaining power due to presence of many established brands and product differentiation. However, importance of infection control increases their dependence on disinfectant products.
Bargaining power of suppliers: The suppliers have low to moderate bargaining power due to availability of substitute raw materials and chemicals. Regulations ensure quality standards.
Threat of new substitutes: Other alternatives for disinfection include alcohols, bleach, etc. but established disinfectants continue to have advantages of being skin-friendly and with broad-spectrum efficacy.
Competitive rivalry: Intense due to presence of global and regional vendors competing on product quality, innovation and pricing. Brand reputation and customer loyalty are also differentiating factors.
Key Takeaways
The global Hospital Surgical Disinfectants Market is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to increasing prevalence of hospital-acquired infections and rising awareness about infection control measures.
North America dominates the global hospital surgical disinfectants market due to advanced healthcare infrastructure and stringent regulations regarding infection control and sterilization. Asia Pacific is expected to witness fastest growth owing to growing medical tourism, rising healthcare expenditures and increasing surgical procedures in the region.
Key players operating in the hospital surgical disinfectants market are 3M Company, Reckitt Benckiser Group plc, Ecolab Inc., Steris plc, Cardinal Health, Becton, Dickinson and Company, Kimberly-Clark Corporation, Bio-Cide International Inc., Shandong Weigao Group Medical Polymer Company Limited, Carenow Medical Pvt. Ltd., B.Braun Melsungen AG, HARTMANN GROUP, Merck KGaA, Entaco Ltd., Medalkan, Medichem S.A., Ruhof Healthcare, Clinicept Healthcare, Integra LifeSciences Holdings Corporation, Micro-Scientific, LLC.
Read More: https://www.pressreleasebulletin.com/hospital-surgical-disinfectants-market-scope/
